| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Revenue | $422.2M | +106.1% |
| Cost of Revenue | $144.2M | +76.5% |
| Gross Profit | $278.0M | +125.8% |
| R&D Expense | $207.0M | +51.9% |
| SG&A Expense | $162.7M | +74.0% |
| Operating Income | -$402.6M | -50.6% |
| Interest Expense | $1.8M | +132.5% |
| Pre-tax Income | -$384.3M | -42.3% |
| Income Tax | -$5.6M |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $137.9M | -91.7% |
| Short-term Investments | $485.6M | — |
| Accounts Receivable | $151.5M | +49.3% |
| Current Assets | $914.7M | -49.7% |
| Total Assets | $2.26B | +10.6% |
| Current Liabilities | $473.3M | +68.2% |
| Total Liabilities | $602.2M | +53.9% |
| Line Item | 2023-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$193.3M | -102.2% |
| Capital Expenditures | $5.0M | +35.6% |
| Investing Cash Flow | -$1.31B | -6548.8% |
| Financing Cash Flow | $36.3M | -97.4% |
| Free Cash Flow | -$198.2M | -99.8% |
| -659.1% |
| Net Income | -$378.7M | -39.7% |
| EPS (Basic) | -$1.36 | +12.8% |
| EPS (Diluted) | -$1.36 | +12.8% |
| Stockholders' Equity |
| $1.66B |
| +0.4% |